UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 330

Sortiert nach

Systematic review: probiotics in the management of lower gastrointestinal symptoms – an updated evidence‐based international consensus

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (8), p.1054-1070

2018

Link zum Volltext

Verfügbarkeit prüfen

Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence‐based international guide

Alimentary pharmacology & therapeutics, 2013-10, Vol.38 (8), p.864-886

2013

Link zum Volltext

Verfügbarkeit prüfen

A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852)

Annals of oncology, 2017-03, Vol.28 (3), p.505-511

2017

Link zum Volltext

Verfügbarkeit prüfen

Topical butyrate for acute radiation proctitis: randomised, crossover trial

The Lancet (British edition), 2000-10, Vol.356 (9237), p.1232-1235

2000

Link zum Volltext

Verfügbarkeit prüfen

Phase 0 studies in gynecologic malignancies are feasible and acceptable to patients

Gynecologic oncology, 2013-07, Vol.130 (1), p.e65-e66

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Paclitaxel and Valspodar (PSC 833) in Refractory Ovarian Carcinoma: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2001-06, Vol.19 (12), p.2975-2982

2001

Link zum Volltext

Verfügbarkeit prüfen

1194 CHARACTERIZATION OF VIRAL ESCAPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH BMS-791325 AND PEGYLATED INTERFERON-ALFA AND RIBAVIRIN

Journal of hepatology, 2012-04, Vol.56, p.S473-S473

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar

British journal of cancer, 2005-07, Vol.93 (1), p.46-53

2005

Link zum Volltext

Verfügbarkeit prüfen

Modulation of the Multidrug Resistance P-Glycoprotein: Detection with Technetium-99m-Sestamibi In Vivo

The Journal of nuclear medicine (1978), 1997-03, Vol.38 (3), p.369-372

1997

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies

Annals of oncology, 2008-10, Vol.19 (10), p.1742-1748

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of Paclitaxel in Combination With a Multidrug Resistance Modulator, PSC 833 (Valspodar), in Refractory Malignancies

Journal of clinical oncology, 2000-03, Vol.18 (5), p.1124-1134

2000

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of Escalating Doses of Paclitaxel Combined With Fixed Doses of Cisplatin and Doxorubicin in Advanced Endometrial Cancer and Other Gynecologic Malignancies: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2001-02, Vol.19 (4), p.1021-1029

2001

Link zum Volltext

Verfügbarkeit prüfen

Processing of Alzheimer β/A4 Amyloid Precursor Protein: Modulation by Agents that Regulate Protein Phosphorylation

Proceedings of the National Academy of Sciences - PNAS, 1990-08, Vol.87 (15), p.6003-6006

1990

Link zum Volltext

Verfügbarkeit prüfen

P.164 APPROPRIATE INDICATION FOR COLONOSCOPY AND HIGH ADENOMA DETECTION RATE

Digestive and liver disease, 2010, Vol.42, p.S160-S160

2010

Link zum Volltext

Verfügbarkeit prüfen

T.06.9: PT1 CANCER OF THE COLON AND RECTUM (CCR): RETROSPECTIVE EVALUATION AND FOLLOW-UP IN REAL PRACTICE

Digestive and liver disease, 2024-04, Vol.56, p.S252-S253

2024

Link zum Volltext

Verfügbarkeit prüfen

FOLLOW UP OF FUNDIC GLAND POLYPS: THEY ARE NOT PRECANCEROUS LESIONS

Digestive and liver disease, 2009, Vol.41, p.S85-S86

2009

Link zum Volltext

Verfügbarkeit prüfen

OC.06.7 MULTIPLE FAECAL TESTS (COLON PANEL) FOR THE DETECTION OF COLON CANCER: A NEW STRATEGY FOR APPROPRIATE PRIORITIZATION OF SCREENING REFERRALS? PRELIMINARY EXPERIENCE IN ITALY

Digestive and liver disease, 2010, Vol.42, p.S86-S86

2010

Link zum Volltext

Verfügbarkeit prüfen

A phase 1/2 trial of a monoclonal antibody targeting fucosyl GM1 in relapsed/refractory small cell lung cancer (SCLC): Safety and preliminary efficacy

Annals of oncology, 2016-10, Vol.27, p.vi494-vi494

2016

Link zum Volltext

Verfügbarkeit prüfen

Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: Lack of correlation

International journal of cancer, 1997-09, Vol.72 (6), p.949-954

1997

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of rubitecan and gemcitabine in patients with advanced malignancies

Annals of oncology, 2002-11, Vol.13 (11), p.1819-1825

2002

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in Stage IIIB Inflammatory Breast Cancer

Journal of clinical oncology, 1999-07, Vol.17 (7), p.2006-2014

1999

Link zum Volltext

Verfügbarkeit prüfen

Overcoming drug resistance in ovarian carcinoma

Current oncology reports, 2001, Vol.3 (1), p.19-26

Fracasso, P M

2001

Link zum Volltext

Verfügbarkeit prüfen

A phase 2, fast real-time assessment of combination therapies in immuno-oncology trial in patients with advanced non-small cell lung cancer (FRACTION-lung)

Annals of oncology, 2016-10, Vol.27, p.vi451-vi451

2016

Link zum Volltext

Verfügbarkeit prüfen

Failure to Diagnose Colorectal Carcinoma at Colonoscopy

Endoscopy, 2004-12, Vol.36 (12), p.1126-1126; author reply 1127

2004

Link zum Volltext

Verfügbarkeit prüfen

Management of locally advanced carcinoma of the breast: II. Inflammatory carcinoma

Cancer, 1994-01, Vol.74 (S1), p.466-476

1994

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 330

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(279)
Mit Volltextzugriff
(256)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(171)
Humans
(149)
Life Sciences & Biomedicine
(146)
Male
(104)
Female
(96)
Middle Aged
(85)
Adult
(82)
Biological And Medical Sciences
(78)
Medical Sciences
(61)
Aged
(58)
Animals
(52)
Oncology
(49)
Pharmacology. Drug Treatments
(34)
Rats
(29)
Antineoplastic Agents
(24)
Technology
(21)
Biochemistry & Molecular Biology
(19)
Engineering
(19)
Fundamental And Applied Biological Sciences. Psychology
(19)
Tumors
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Systematic review: probiotics in the management of lower gastrointestinal symptoms – an updated evidence‐based international consensus

Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence‐based international guide

A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852)

Topical butyrate for acute radiation proctitis: randomised, crossover trial

Phase 0 studies in gynecologic malignancies are feasible and acceptable to patients

Phase II Study of Paclitaxel and Valspodar (PSC 833) in Refractory Ovarian Carcinoma: A Gynecologic Oncology Group Study

1194 CHARACTERIZATION OF VIRAL ESCAPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH BMS-791325 AND PEGYLATED INTERFERON-ALFA AND RIBAVIRIN

Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar

Modulation of the Multidrug Resistance P-Glycoprotein: Detection with Technetium-99m-Sestamibi In Vivo

Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies

Phase I Study of Paclitaxel in Combination With a Multidrug Resistance Modulator, PSC 833 (Valspodar), in Refractory Malignancies

Phase I Trial of Escalating Doses of Paclitaxel Combined With Fixed Doses of Cisplatin and Doxorubicin in Advanced Endometrial Cancer and Other Gynecologic Malignancies: A Gynecologic Oncology Group Study

Processing of Alzheimer β/A4 Amyloid Precursor Protein: Modulation by Agents that Regulate Protein Phosphorylation

P.164 APPROPRIATE INDICATION FOR COLONOSCOPY AND HIGH ADENOMA DETECTION RATE

T.06.9: PT1 CANCER OF THE COLON AND RECTUM (CCR): RETROSPECTIVE EVALUATION AND FOLLOW-UP IN REAL PRACTICE

FOLLOW UP OF FUNDIC GLAND POLYPS: THEY ARE NOT PRECANCEROUS LESIONS

OC.06.7 MULTIPLE FAECAL TESTS (COLON PANEL) FOR THE DETECTION OF COLON CANCER: A NEW STRATEGY FOR APPROPRIATE PRIORITIZATION OF SCREENING REFERRALS? PRELIMINARY EXPERIENCE IN ITALY

A phase 1/2 trial of a monoclonal antibody targeting fucosyl GM1 in relapsed/refractory small cell lung cancer (SCLC): Safety and preliminary efficacy

Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: Lack of correlation

Phase I study of rubitecan and gemcitabine in patients with advanced malignancies

Outcomes of High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in Stage IIIB Inflammatory Breast Cancer

Overcoming drug resistance in ovarian carcinoma

A phase 2, fast real-time assessment of combination therapies in immuno-oncology trial in patients with advanced non-small cell lung cancer (FRACTION-lung)

Failure to Diagnose Colorectal Carcinoma at Colonoscopy

Management of locally advanced carcinoma of the breast: II. Inflammatory carcinoma

Suchergebnisse filtern